Analisis Faktor Risiko Terhadap Penyakit Jantung Koroner di Ruang ICCU RSUDZA Banda Aceh

Fuadi Fuadi, Alma Aleta

Abstract


The high incidence of coronary heart disease cases is strongly associated with high cases of metabolic syndrome in the communities. In many current studies that have been carried out, the topic of metabolic syndrome in Aceh is not comprehensively conducted or reported. Furthermore, the research related to risk factors of coronary heart disease. Not only the risk factors, but also the researcher also observed the relationship of the disease risk with metabolic syndrome in hospitalized patients. This study is designed with quantitative research based on Cross-Sectional method. The population of the research are those people who are diagnosed by the cardiologist as coronary heart disease (CHD) patients through Unstable Aegina Pectoris (UAP), NSTEMI and STEMI in Intensive Cardiology Care Unit  room of RSUDZA Banda Aceh. the total sample for this research are 60 respondents. The schedule period for the conducted research is started from January 13, 2018 until May 31, 2018. Moreover, the researcher used nonprobability sampling technique with accidental (convenience) sampling type.Based on the results of the study, it is obtained that: the characteristics of coronary heart disease respondents are 78.33% in adult ages, 41.67% in the elderly ages (46-55 years) and 90% had no coronary heart disease diagnosing history in the family. In addition, the risk factors for coronary heart disease are 70% in metabolic syndrome, 75% in central obesity, 71.67% in hypertension, 53.33% in diabetes mellitus, 33.33% in hyper triglycerides, 81.67% in hypo-HDL, and 75% had smoking records. Statistically, the study reveals that there is no relationship between metabolic syndrome and coronary heart disease. It is proved by metabolic syndrome (p-value 0.360), central obesity (p-value 0.882), hypertension (p-value 0.807), diabetes mellitus (p-value 0.740), hyper triglyceride (p- value 0.970), and smoking records (p-value 0.519). On the contrary, there is significant relationship between coronary heart disease and hypo-HDL (p-value 0.043).

Full Text:

PDF

References


DAFTAR PUSTAKA

Jevuska. Epidemiologi Penyakit Tidak Menular, Penyebab, Contoh & Pencegahan. 2010.

WHO. Penyakit Cardiovascular Diseases. Media Centre: Fact sheet, 2016.

Majid A. Patofisiologi, Pencegahan Dan Pengobatan Terkini Penyakit Jantung Koroner. 2007.

Riskesdas. Badan Penelitian Dan Pengembangan Kesehatan Kementerian Kesehatan Ri. 2013.

Soewondo P, Purnamasari D, Oemardi M, Waspadji S and Soegondo S. Prevalence of metabolic syndrome using NCEP/ATP III criteria in Jakarta, Indonesia: the Jakarta primary non-communicable disease risk factors surveillance 2006. Acta Med Indones. 2010; 42: 199-203.

Peter W.F, Wilson M, Ralph B. D’Agostino P, Helen Parise S, Lisa Sullivan P and James B. Meigs M, MPH. Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus. AHA Circulation. 2005; 112.

Ford.Md M, Earl S. . Risks for All-Cause Mortality,Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome. Diabetes care. 2005; 28: 1769-78.

PERKI. Pedoman Tatalaksana SIndrom Koroner Akut. 2015.

Rilantono PLI. Penyakit Kardiovaskuler (PKV) 5 Rahasia. Fakultas Kedokteran Universitas Indonesia, 2012.

Rini S. Sindrom Metabolik. J Majority, 2015.

Adrianjah H and Adam J. Sindroma metabolik: pengertian, epidemiologi, dan kriteria diagnosis. Informasi laboratorium prodia. 2006.

Azizi F, Salehi P, Etemadi A and Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes research and clinical practice. 2003; 61: 29-37.

Ford ES, Giles WH and Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama. 2002; 287: 356-9.

Mentari Rosriyana Dewi, Dwi Susi Haryati and Sumardino. Faktor-Faktor Dominan Sindrom Metabolik Yang Berhubungan Dengan Kejadian Akut Miokard Infark (AMI) Di Ruang Intensive Cardiovaskuler Care Unit (ICCU) Rsud Dr. Moewardi Tahun 2014. 2014.

Arsenault BJ, Despres JP, Stroes ES, et al. Lipid assessment, metabolic syndrome and coronary heart disease risk. European journal of clinical investigation. 2010; 40: 1081-93.

Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes care. 2001; 24: 683-9.

Lakka H-M, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama. 2002; 288: 2709-16.

Girman CJ, Rhodes T, Mercuri M, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS). The American journal of cardiology. 2004; 93: 136-41.

Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004; 110: 1245-50.

Galassi A, Reynolds K and He J. Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis. The American Journal of Medicine. 2006; 119: 812-9.

Eckel RH, Grundy SM and Zimmet PZ. The metabolic syndrome. The Lancet. 2005; 365: 1415-28.

Lannywati Ghani MDSdHN. DOMINANT RISK FACTORS OF CORONARY HEART DISEASE IN INDONESIA. 2016.

Després J-P and Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444: 881.

Goff Jr DC, D'Agostino Jr RB, Haffner SM and Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism. 2005; 54: 264-70.

Tchernof A, Lamarche B, Prud'homme D, et al. The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes care. 1996; 19: 629-37.

Kathiresan S, Otvos JD, Sullivan LM, et al. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation. 2006; 113: 20-9.

CDC CFDCaP. LDL dan HDL Kolesterol. 2017.


Refbacks

  • There are currently no refbacks.




Lisensi Creative Commons
Aceh Medika oleh LPPM Universitas Abulyatama disebarluaskan di bawah Lisensi Creative Commons Atribusi 4.0 Internasional.
Berdasarkan ciptaan pada http://jurnal.abulyatama.ac.id/index.php/acehmedika.